chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red itchy rash all over body; itchy rash all over body; there would first be raised welts; Rash appeared monday morning after the 2nd dose; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 26Feb2021 at 02:00 PM (at the age of 43 years old) as DOSE 2, SINGLE DOSE for covid-19 immunization. The patient was not pregnant at the time of the vaccination. The patient medical history was not reported. No known allergies reported. Concomitant medication included escitalopram oxalate (LEXAPRO) taken for an unspecified indication, start and stop date were not reported. The patient previously took bnt162b2 (Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 12Feb2021 at 03:30 PM as DOSE 1, SINGLE DOSE for covid-19 immunization. No other vaccines were received within four weeks prior to the administration of bnt162b2. On 01Mar2021 at 07:00 AM, Monday morning after second dose, the patient developed red itchy rash all over body. As spread to new areas, there would first be raised welts. The events resulted in visit to doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result the events which included unspecified oral steroid. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The outcome of the events was recovering.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Redness, swelling and tenderness.   Redness just below vaccine site, moving inward toward inner arm, approximately 1.5 inches in width.  Warmth is present on affected area.
Severe chest pain for over a year, extreme tiredness, no energy, panic attacks, extreme loss of weight
pt recv vax 21OCT97 & devel redness around inj site w/itching followed by hives & sensation of thick tongue & diff swallowing;
received vaccine 8 days ago and now may have cancer; This is a spontaneous report from a Pfizer-sponsored program. A male patient of an unspecified age received BNT162B2 (BNT162B2) via an unspecified route of administration on 26Apr2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received vaccine 8 days ago and now may have cancer on an unspecified date. A contactable consumer (patient's mother) was asking for timeframe information between covid vaccine and image screening for cancer, son recieved vaccine 8 days ago and now may have cancer, imaging not yet confirmed diagnosis. Outcome of the event was unknown.  Information on batch number has been requested.
Fever CHILLS, MUSCLE AND JOINT PAIN, STIFFNESS IN JPOINTS OF LEGS AND HANDS Narrative: FEVER AND MUSCLE PAIN RESPONDED TO  ACETAMINOPHEN AND IBUPROFEN SX LASTED SLIGHTLY  OVER A DAY AND A HALF
Patient already received 1 dose of Moderna Bivalent on 9/15/2022 (LOT: AS7143C, EXP: 5/20/2023). Today she received by mistake another Moderna Bivalent (LOT: 020H22A, EXP: 5/30/2023)  Patient right now says she feel fine. There is no sign of adverse effect.
Swollen lymph nodes 4 days after 2nd dose; Administration date 21Feb2021, dose number=2/ administration date 03Feb2021, dose number=1; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 21Feb2021 at 13:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. It was unknown if the patient had any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any other medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 03Feb2021 at 16:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 25Feb2021 at 12:00, the patient experienced swollen lymph nodes, 4 days after the second dose. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of event reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
grandma reported fever 105 & lethargy w/in 48hr p/vax;
Approx. 15 min after receiving the vaccine, the client experienced numbness in her fingertips and her two fingers on the outer side of her rt hand.  The mother was contacted the next day and she stated that this lasted all night; in the morning the client was fine.  The client received her 1st dose of HPV on Jan 15, 2008, the mother stated that after that dose her left hand was numb for several hrs but then resolved itself.
At 11:34, pt. stated ?dizziness?. VS BP 132/80, P 69, Resp. 18, Temp. 97.8, O2 sat 97% on RA. Resp=unlabored, Lung sounds clear. At 11:47 pt. reassessed, denied dizziness, stated, ?I feel fine? ?OK? VS BP 120/68, P77, Resp. 18 = unlabored. Temp. 98, O2 Sat 98% on RA. Encouraged pt. to stay until 12:04. At 12:04 pt. continued to state no more dizziness stated, ?I feel fine? and expressed desire to go home. Pt. alert and oriented to person, place, and time. Pt. cleared and discharged to home. RN
Patient reported large bruise of groin with no trauma. labs completed and normal. bruise improved with time.  she also was found with a false positive HIV antibody screen  on 9/9/2021. unclear if related to vaccine.
Approximately 24 hours after my Booster (3rd covid shot) I experienced sudden onset moderate to severe tinnitus that has been constant from 11/27/2021.
Itchy welts and rash, some in clusters, some individual. Welts mostly on neck, trunk but also arms, leg and face. Worse breakout after 2nd shot
After receiving the second Moderna vaccine, I have been experiencing acute pain in my upper right and left chest area at the top of my rib cage.  After two weeks of acute pain, I was seen at my PCP and a chest x-ray was performed. Nothing showed up on the chest x-ray, but I continue to experience pain.
fever (temp not taken @ home by parent), prolonged crying, nausea, vomiting, diarrhea; examined @ hosp ER on 28JUL94 & found to be in good condition;
Immediately after vaxs, had rxn in left VL, a raised red rash from hip to knee and splotchy red rash on rt. VL from hip to foot. Gave Benadryl 25mg, SQ.
The following symptoms started on August 16, 2021: Positional vertigo, nausea, dizziness, ringing in ears, sensitivity to light, sensitivity to sound, difficulty focusing, loss of balance, vibrating head sensations, migraines, head pressure. These symptoms are persistent and have caused substantial disruption of my ability to conduct normal life functions.
Started feeling tingling and numbing sensation in foot weeks after and sever muscle weakness 2 to 3 months after. Was admitted to hospital in August due to irregular heart beat and fluctuated blood pressure. Was treated for autoimmune disease in August by taking Prednizone and medication that regulates the heart beat
TOOK SECOND COVID BOOSTER AND WAS FEELING BLAH; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (TOOK SECOND COVID BOOSTER AND WAS FEELING BLAH) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) Solution for injection in pre-filled pen, Citrate free. On an unknown date, the patient experienced FEELING ABNORMAL (TOOK SECOND COVID BOOSTER AND WAS FEELING BLAH). At the time of the report, FEELING ABNORMAL (TOOK SECOND COVID BOOSTER AND WAS FEELING BLAH) was resolving.            No concomitant medications were reported. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No treatment information was reported.
Felt out of equilibrium day following 2nd shingrix, worsened the next 2 days to the point he had to hold onto something to be safe, resolved over the next 48 hours.
Numb feeling in arm that began to resolve itself within 15 mins. Pt does not wish to be contacted.
PATIENT SAID HER ARM BECAME RED AND SWOLLEN DOWN TO HER ELBOW.
Initially, a red bump that started itching a month or so later, about the size and look of a mosquito bite. Gradually started to hurt, got a little bigger, and now, a year later, it was started to sort of sting or throb. Hurts to touch, especially to scratch.
Right arm 5.75x6 in area of induration and tenderness increase warmth, tender to touch Not >60% circumferential
Patient was hospitalized for over a week with COVID Pneumonia. Patient doesn't know how he was exposed but doctor said he was lucky to be living. Patient has COPD, Congestive heart failure and a host of other pre-existing conditions
itchy feet and hands; This is a spontaneous report from a contactable healthcare professional (patient). A 54-year-old female received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3246 and expiry date: unknown), via an unspecified route of administration on the right arm, on 13Jan2021 15:00 to 13Jan2021 15:00 at SINGLE DOSE for covid-19 immunisation. Medical history included high blood pressure and seasonal allergies. Patient was not pregnant at the time of vaccination. Concomitant medication included high blood pressure medication. There were no other vaccine received within 4 weeks prior to COVID vaccination. On 14Jan2021 13:00, patient woke up with itchy feet and hands. She also was experiencing what felt like a rubber and around her chest. The next day on 15Jan2021, it had spread to my legs and arms, and then the next day it was on my back and chest. As of 26Jan2021, it has moved to her neck and face. Patient had been using Benadryl orally, and Cortizone Topical in the areas. Outcome of the event was not recovered. Event was considered non-serious. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.
Headache lasting more than 7 days; Itching entire body; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 08Apr2021 at 14:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergies, anxiety, hypothyroidism and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC), sertraline hydrochloride (ZOLOFT), montelukast sodium (SINGULAIR), vitamin b complex (MANUFACTURER UNKNOWN) and magnesium (MANUFACTURER UNKNOWN); all from unknown dates for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took Hepatitis b vaccine and experienced allergy to the vaccine. On 08Apr2021 at 15:15, the patient experienced headache lasting more than 7 days and itching entire body. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events.  Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was recovering while that of the itching entire body was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
At 11:30 PM chills began.  I could not stay warm.  I wrapped up in warm blankets.  I could not sleep.  My skin felt tender to touch.  Points of arthritis was extremely painful.  Fever got up to 100 degrees.  Fever broke around 7 am the next morning.  I felt tired and weak that day.  By 2nd morning began to feel better.   Since that time I seem to be having inflammation issues.
shingles; rash; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number 2Y9R4, expiry date 28th June 2021) for prophylaxis.   In March 2019, the patient received the 1st dose of Shingrix. In August 2019, less than 5 months after receiving Shingrix, the patient experienced shingles and rash. On an unknown date, the outcome of the shingles and rash were unknown.   It was unknown if the reporter considered the shingles and rash to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient received first dose of Shingrix in March 2019 and developed a rash on part of his body in August 2019. The rash was diagnosed as shingles. The reporter consented to follow up.
Information has been received on 1/31/02 from an RN concerning a female who "last week" was vaccinated with a dose of pneumococcal vaccine 23 polyvalent. Subsequently, the pt had warmth, tenderness and swelling. The pt sought unspecified medical attention. Two other pts had a similar experience (WAES 0202USA00011 and 0202USA00146). It was also reported that 1 of these 3 pts had "swelling down to her elbow, 6" or more" and as of 1/31/02, is still experiencing tenderness and redness. No further information is expected.
Pt reported to have numbness and tingling in the left arm that started 2 days after the administration of the vaccine.  The side effects have continued continuously since the onset.
breakthrough infection 6/08/2022, fever, headache, body aches, sinus congestion, fatigue. Fever ended 6/9 morning. Began Paxlovid 6/10 evening. Symptoms abated; continued fatigue.
Pregnant patient received COVID Pfizer Vaccine at 6 weeks pregnant. Patient reported stillbirth on 21-November-2021.
Within less than 30 minutes developed tightness in chest; within few minutes developed tremors - violent at times. Also nausea with dry heaves.  BP 162/94. Given 50 mg Benadryl IM IV started. Given  Zophran IV
fever, prolonged (multiple months) severe diarrhea, screaming, head banging, poop smearing, regression in gross motor skills, complete lack of eye contact, stopped babbling
On April 25, 2021 around 12:40pm I was just sitting at church reading my assignment.  After reading it i stood up and in my right eye i was seeing objects.  They looked like squiggle lines or worms.  I do not see them as much now but the sight in my right eye haven't been the same.
got terrible rashes; This spontaneous case was reported by a consumer and describes the occurrence of RASH (got terrible rashes) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (got terrible rashes). At the time of the report, RASH (got terrible rashes) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Neutrophil count: low (Low) low. On an unknown date, White blood cell count: low (Low) low.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-399806 (Patient Link).
Sever ringing in left ear. It lasted for about 2-3 hours. The ringing has lessened but not back to normal. Almost there.
Started with lesion on legs 7/17-18: by 7/21 also on left shoulder and right hand. Mom thought bug bites. Did nothing, saw doctor 7/21/04; prescribed Bactroban and use of Benadryl , rev on 7/23: no new lesions: definitely varicella scabbed over.
A non-serious spontaneous report of administration of full dose of H1N1 vaccine in one nostril was received from a certified medical assistant concerning an adult. The patient's medical history and concomitant medications were not provided. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.
This is a spontaneous report from a contactable pharmacist. A 75-year-old female patient of an unspecified ethnicity received first dose of PREVNAR 13 (Lot: J53435 Expiration date: Nov2015; NDC:00005197101), on 14Jan2015 at 15:30 intramuscular on left deltoid at 0.5 ml, single. Concomitant medication included simvastatin for hyperlipidemia since more than 1 year at 40 mg daily at bed time and citalopram for depressive disorder since more than 1 year at 20 mg daily. The patient medical history and was not reported. On 15Jan2015, the patient experienced site swollen, site was very red and site was hard. The events were describes as follows: over the past two days, the injection site has been increasingly red, swollen, hard and it was the size of a half dollar. The events worsened. Events did not require emergency room or physician visit, no treatments given. The patient has recovered from the events on 22Jan2015. Follow-up (09Feb2015): New information received from the same contactable pharmacist includes: vaccination and events details, concomitant medications. Follow-up (10Mar2015): New information received from the same contactable pharmacist includes: reaction data (onset date) and outcome (recovered). Follow-up attempts completed. No further information expected.
This case was reported by a other health professional via sales rep and described the occurrence of shingles in a 85-year-old female patient who received SHINGRIX. The patient's past medical history included shingles. On 16th April 2018, the patient received the 1st dose of SHINGRIX. On 8th May 2018, 22 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The patient had a history of shingles. The office manager reported that after vaccination with SHINGRIX the patient was seen by provider. The provider reported that 24 to 48 hours prior the patient had symptoms of shingles. On 8th May 2018, the shingles was confirmed during the visit.
This spontaneous report was received from a medical assistant who reported that (Oka/Merck) PROQUAD reached temperatures that were outside the prescribing information. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Area was bright red and warm to the touch. Patient experienced fever, chills, headache, shaking, back and neck muscle aches, and patient used Aleve to help these symptoms.
No adverse effects reported.; an unspecified number of patients received improperly stored dose of RECOMBIVAX, GARDASIL 9, MMRII, or PROQUAD; The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify.  Follow-up information has been received from the practice manager on 18-SEP-2018.  This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided.       On 12-JUN-2018, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant Human albumin) (strength and route were unknown) (lot#  N024562 and expiration date 06-MAR-2019) for prophylaxis (Incorrect product storage). The sterile diluent (MERCK STERILE DILUENT) was properly stored. No adverse event was reported.  The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001959:
Arm soreness- mild, 2 days Headache - mil,  20-60 minutes Diarrhea - mild,  1 day Fatigue - mild, .5 day
Thick mucus in mouth, wheezing,difficulty breathing,  fever behavior changes. fever showed up day of shot. and other symptoms showed up the next day and so far has lasted 2 days.
Pt admitted on 01/31/22 for left lacunar stroke - acute onset of right-sided weakness and right facial droop. Endorses mild blurry vision, difficulty speaking, and getting his thoughts. Pt was treated with TPA with no complications, initiated on dual antiplatelet therapy - discharged on 02/03/22.
After waking up from a nap approximately one hour after vaccines patient had uncontrollable crying/agitation.  This lasted for three hours.  She was seen back in office and was very agitated.  I was able to give bottle and she napped with multiple episodes of waking up screaming.  When she woke up she was back to normal and has been her normal self since.